Received Sep 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | Z006076 | — |
a right upper and lower lobe pulmonary embolism; congestion; This spontaneous report was received from a Nurse Practitioner and refers to a male patient of unknown age. The patient's medical history included 2 occurrences of pulmonary embolism (in 2017 and 2020). His concurrent conditions and concomitant therapies were not reported. On 16-JUL-2025, the patient was vaccinated with pneumococcal 21-valent conjugate vaccine (CAPVAXIVE) solution for injection, strength: 168 mcg/mL, at a total dose of 0.5 mL, lot #Z006076, expiration date: 11-SEP-2026, administered for prophylaxis (route of administration and anatomical location were not reported). On 18-JUL-2025, the patient returned to the office with congestion and chest discomfort. That day, coronavirus disease (COVID) test was negative, and his lung sound was decreased. The patient was sent to the Emergency Room. On an unspecified date in approximately July 2025, the patient was hospitalized and diagnosed with a right upper and lower lobe pulmonary embolism. He was not on anticoagulant at the time of the hospitalization. At the reporting time, the patient recovered from both events. Causality assessment was not provided.
Medical History/Concurrent Conditions: Pulmonary embolism;
Test Date: 20250718; Test Name: lung sound; Result Unstructured Data: decreased; Test Date: 20250718; Test Name: COVID test; Test Result: Negative